Advertisement

Topics

AI and pharmacovigilance: ‘We can cut out a lot of this work and focus our energies,’ says MHRA

10:04 EDT 10 Jul 2019 | Outsourcing-Pharma

Pharma and regulators are using machine learning to accelerate various pharmacovigilance activities â as the number of adverse event reports increases 10-12% each year, says Eli Lilly advisor.

Original Article: AI and pharmacovigilance: ‘We can cut out a lot of this work and focus our energies,’ says MHRA

NEXT ARTICLE

More From BioPortfolio on "AI and pharmacovigilance: ‘We can cut out a lot of this work and focus our energies,’ says MHRA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...